Pulmonary edema (PE) is defined as a state with exces sive extravascular lung fluid, generally resulting from increasing hydrostatic pressure or hyperpermeability in the pulmonary capillary bed (1) . The disorder sometimes appears as a manifestation of heart failure. Although many common causes of PE are due to combinations of both mechanisms, cardiogenic PE is mainly attributable to hydrostatic etiology.
Key factors that contribute to the onset of heart failure are excess activity of the sympathetic nervous system and that of the renin-angiotensin system (RAS). The former contribution has been well-documented by numerous studies including those of adrenaline-induced PE (2-7). Also concerning RAS, recent studies have implied its importance in the development of heart failure. In parti cular, angiotensin II (All) is considered to play a leading role in its onset, since it produces strong vasoconstriction and increases systemic arterial pressure. However, most studies relating to All have shown only an indirect con nection, such as efficacy of angiotensin converting en zyme inhibitors against heart failure (8). Our literature survey found little direct evidence proving the induction of heart failure by All. In 1995, Shimakura et al. first revealed that intravenous All injection can produce PE in rats, possibly as a result of increasing afterload (9), but the relationship between this form of PE and heart failure has not yet been fully elucidated. Additionally, because the vasoconstrictive response to All is widely different among species (10), it remains unclear whether such PE occurs after All administration in other animals besides rats. To our knowledge, no studies using rabbits have reported the development of PE by All (11, 12). We therefore undertook the present study in order to: 1) pro pose an experimental procedure for inducing PE by in travenous administration of All in rabbits, 2) find key factors that indicate the connection between the PE and heart failure and 3) examine the effect of pretreatment with losartan, a nonpeptide type-1 All receptor antago nist, on the PE model.
The data presented show that the incidence of PE in creases with a higher dose of All that is given continu ously to rabbits and that this form of PE is attributable to increasing afterload and following heart failure. Addi tionally, losartan can prevent the induction of PE, prob ably by a suppressive effect on the BP elevation that is induced by AII. Fig. 1 . Determination of the area under the systolic blood pressure (BP)-time curve corrected by baseline BP (cAUC). The solid curve shows the sequence of change in systolic BP after angiotensin II (All) administration. The white arrow indicates when All infusion was started. Systolic BP just before All administration was regarded as the baseline (indicated by the broken line). The values determined by systolic BP minus baseline BP (H) were recorded every minute while systolic BP stayed above the baseline, and these were all integrated as cAUC. BP values below the baseline were regarded as zero.
MATERIALS AND METHODS

Protocol and general procedures
Male rabbits (n = 63), weighing 2.5 3.0 kg (Kanamaru Animal Lab., Saitama), were housed under controlled conditions for at least one week before the experiments. The rabbits were randomly divided into 9 groups of 7 rabbits each. Animals in the first 7 groups were assigned to receive various doses of All, while those in the other 2 groups were used to test the effect of losartan on All induced PE.
Each rabbit was anesthetized with pentobarbital so dium (30 mg/kg, i.v.) via the ear vein and then fixed on its back. A polyethylene tube (PE-190) was inserted into the left femoral artery, for monitoring arterial blood pressure (BP) (blood pressure transducer, E10-PZ; Nihon Koh den, Tokyo) and its differentiated value (dP/dt) (differen tiator, ED-601G; Nihon Kohden). The left femoral vein was also catheterized by another tube (PE-50) for injec tions. For monitoring respiratory movement (RM), a thermister pickup (Nihon Kohden) was attached to the nose which detects respiratory air flow. BP, dP/dt and RM were simultaneously recorded with a thermister array recorder (RM-7000, Nihon Kohden). Heart rate and res piratory rate were counted by the resulting records. Using a heating blanket, the body temperature of the rabbit was maintained at 39-401C throughout the experiment.
For the first experiment, All was dissolved in saline at the concentrations of 125, 250, 375 and 750 ug/ml before use (pH 6-7). By means of either continuous i. pg/kg, bolus i.v. As a control, the same volume of saline alone was given to another group by c.i.v.
In the experiment for evaluating the preventive effect, losartan was dissolved in saline to prepare solutions of 2 mg/ml and 12 mg/ml. Ten minutes before All adminis trations, solutions at the volume of 0.25 ml/kg (0.5 mg/kg and 3 mg/kg, respectively) was injected as a bolus to each of 7 rabbits. The animals received the edemato genic dose of All that was determined according to the dose-incidence relationship in the initial study. The other procedures were same as those in the first experiment.
Measurements of indices and evaluation of pulmonary edema When All was given alone, systolic BP just before All administration was regarded as baseline. After the intro duction of All, the difference between the peak systolic BP and the baseline BP (Dmax) was obtained as an index of an increase in BP. Additionally, the area under the systolic BP-time curve corrected by baseline BP (cAUC) was determined as a parameter that reflects both the degree of a rise in BP and its persistent time, according to the trapezoidal rule (Fig. 1) . The cAUC actually approxi mates the area surrounded by the systolic BP-time curve and the line representing the baseline BP. In the study of losartan, systolic BP was also recorded before and after losartan administration. The latter was regarded as the baseline BP.
Ten minutes after the end of the administration of All, every rabbit was euthanatized by exanguination via the femoral artery; then the lung was immediately excised, and the attached tissues were trimmed away. The de velopment of PE was judged by froth or liquid running through the bronchi when the lungs were removed (severe PE) or when they were squeezed gently (mild PE). Only lungs whose bronchi produced no froth when squeezed were regarded as negative. After measurement of the wet lung wt., the lungs were dried at 70 *C for 48 hr to obtain the dry lung wt. The wet-dry lung wt. ratio (wet/dry wt., WDR) was calculated in every rabbit to quantify the ex cess water retention in the lung.
Test agents
Losartan (losartan sulfate) was a gift of Banyu Phar maceutical Co., Ltd. (Tokyo). Angiotensin II (angioten sin II, human) was purchased from Nacalai Tesque (Kyoto).
Statistical analyses
All data are expressed as the mean ±S.D. The level of significance used was 0.05, excluding those cases with special notes in parentheses. To compare the means of several groups, one-way analysis of variance was used at first. When a significant difference was found, then Scheffe's method was used to compare the two relevant sets of data. The differences of BPs between before and after pretreatment were tested by the paired t-test. The significance of different probabilities were examined by Fisher's exact probability test. The relationship between two variables was assessed by calculating the correlation coefficient (r). recordings of an animal injected with 150 pg/kg of All are shown in Fig. 2b . In these records, the characteristic feature is the prompt elevation of BP; this change appeared in all the animals that received All alone. However, the reduction patterns of BPs differed widely among the groups. Typically, BP fell more rapidly when All was given a bolus i.v. than it did with c.i.v. adminis tration. In addition, the reduction of BPs were likely to become slower as a higher dose of All was infused. Con cerning heart beat, most of the rabbits had arrhythmias including supraventricular or ventricular ectopic beats and atrioventricular block in the administration period, all of which disappeared within 30 sec. Sinus bradycardia was sometimes observed just after the introduction of All. Typical changes of dP/dt in cases that received c.i.v. administration were as follows: at first, dP/dt decreased immediately after All administration; then it increased until it reached the peak value, and it decreased again gradually. All administrations sometimes depressed the respiratory movement. The respiratory rate showed little change just after the administration of All, but it in creased slowly as BP decreased, in most cases.
Relationship between the incidence of pulmonary edema and the dose of angiotensin II Table 1 summarizes the results in the first experiment. When All was given by c.i.v. (1.2 ml/10 min), the inci dence of PE increased in a dose-dependent manner. The dose-incidence relationship was sigmoid-shaped rather than linear (Fig. 3) . This curve flattened in the dose range of 150 pg/kg and more. Also, cAUCs and WDRs seemed larger with a higher dose of All. Moreover, at a dose of 150 pg/kg, both WDR and the incidence of PE were sig nificantly smaller when All was injected bolus i.v. than when it was given by c.i.v. Similarly, cAUCs of the animals that received All administrations bolus i.v. were smaller than those of the animals given by c.i.v. This difference between the two administration methods seems to reflect the differences in the reduction pattern of BP. On the other hand, Dma, did not differ significantly among the groups (Table 1) .
Based on the results shown in Table 1 , it was deter mined that All would be given by c.i.v. (1.2 ml/10 min) at a concentration of 150 pg/kg in the following experi ment.
Effect of losartan on pulmonary edema Figure 4 represents the actions of losartan on BP, dP/dt and RM in the rabbits. A slight but significant reduction of BP was noted after losartan injection (6±3 mmHg, P <0.05). The higher dose of losartan markedly suppressed the elevation of BP that would be induced by All alone and prevented PE completely. Also in rabbits given a lower dose of losartan, the pretreatment with it reduced the incidence of PE moderately but significantly (P<0.05) ( Table 2) . With regards to dP/dt and RM, the changes observed in animals without the pretreatment were also suppressed, in most cases. Table 1 .
Administration of angiotensin II and the incidence of pulmonary edema
All of the groups consisted of 7 rabbits. Systolic blood pressures (BPs) measured just before angiotensin II (All) administrations were regarded as the baseline, and the differences between the peak and baseline BPs (Dmax) were calculated after All administrations. The incidence of pulmonary edema (PE) is described as the number of rabbits in which PE developed/the number of rabbits in the group. The other abbreviations are as follows: continuous in travenous infusion for 10 min (c.i.v.), 30 sec of bolus intravenous injection (bolus i.v.), the area under the time systolic BP curve corrected by the baseline (cAUC) and the wet-dry lung weight ratio (WDR). The differences of the means in body weight, baseline BP, Dma,,, cAUC and WDR were tested by one-way analysis of variance. Those in body weight and baseline BP were not significant. *P <0.05, **P <0.01, compared to the control group if not in dicated, by post hoc Sheffe's test; `-'P<0.05, compared to the control group, by Fisher's exact probability test.
Evaluation of the indices Figure 5 shows the relationships in cAUC, WDR and the development of PE. The severity of PE seemed to be well-indicated by WDR. If we judge the results from a critical WDR ratio of 4.9, the probability that edematous lungs may be mistaken for nonedema is 1/19 (5.3%) and vice versa, 3/30 (10%). Concerning cAUC and the PE, both the severity and the incidence of PE were likely to increase as cAUC becomes larger. No cases with cAUCs of less than 300 mmHg • min developed edematous lungs, while most cases with cAUCs of over 500 mmHg • min de veloped severe PE. The correlation between cAUC and WDR was statistically significant (r=0.66, P<0.05). The contribution rate (r2) was 0.44, which means that 44% of a variation in WDR can be explained by the discrepancies in cAUC. 
DISCUSSION
All infused intravenously to rabbits is a very powerful pressor agent. It produces a prompt increase in systemic arterial pressure, most likely as a result of systemic ar terial constriction. In the present study, we successfully produced PE following an elevation in systemic arterial pressure. Concerning this type of PE model, one notable problem is that administration duration of All differs among individuals in proportion to their body weight. However, we think the differences have little influence on the present results because the differences of mean body weights among the groups were not significant and be cause BPs in most rabbits had returned to the baseline within 10 min in this study.
The present results revealed that both the dosage and duration of All given to the rabbits are major deter All of the groups consisted of 7 rabbits. The group of "150, c.i.v." in Table I was taken as the control group . Angiotensin II (All) was given to rabbits by the same method as used for the control group. Systolic blood pressures (BPs) measured just before losartan injections were described as those before losartan, and those just before All administrations were used as the baseline .
The differences between the peak and baseline BPs (D,,,) were calculated after All administrations. The incidence of pulmonary edema (PE) is described as the number of rabbits in which PE developed/the number of rabbits in the group. The other abbrevi ations are as follows: the area under the time-systolic BP curve corrected by baseline (cAUC), the wet-dry lung weight ratio (WDR) and continuous intravenous infusion for 10 min (c.i.v.). The differences of the means among the groups in systolic BP before losartan, Dma,, cAUC and WDR, were tested by one-way analysis of variance. *P<0.05, **P<0.01, compared to the control group if not indicated, by post hoc Sheffe's test; XP<0.05, by the paired t-test; *P<0.05, compared to the control group, by Fisher's exact probability test. Fig. 5 . The relationships among the area under the systolic blood pressure-time curve corrected by baseline (cAUC), wet-dry lung weight ratio (WDR) and the development of pulmonary edema (PE). The closed circles show the cases with severe PE, the half-tone circles show those with moderate PE, and the open circles show those without PE. Generally, both the severity and the incidence of PE are prone to increase with cAUC. WDR seems to reflect the severity of PE, and it moderately correlates with cAUC (r= 0.66, P<0.05).
minants for whether or not PE was induced. When All was infused continuously for about 10 min, the incidence of PE and cAUC increased in relation to the dosage, as shown in Table 1 . Additionally, the duration of All had a great impact on the onset of PE. Concerning the two administration methods of c.i.v. (10 min) and bolus i.v.
(30 sec), the former induced PE more frequently than the latter did. Although we did not try other methods, we can speculate on what would be the results of other administration durations according to the present data. For instance, the administration dose per time of "300 ig/kg/10 min" is substantially equal to that of "150 4ig/kg/5 mm". Supposing that All was given at the rate of "150 ig/kg/5 min", the BP-time curve within the ini tial 5 min must be similar to that of "300 g/kg/ 10 mm". Then, BP will fall soon after the end of All infusion because the half-life of exogenious All in vivo is short (about 70 sec) (13). Consequently, the cAUC of this method will be smaller than that of "300 ug/kg/10 min" and so will the incidence of PE. Similarly, the dose per time of "150 jig/kg/l5 min" and "150 ~g/kg/30 min" are the same as that of "100 ug/kg/10 min" and "50 ug/kg/10 min", respectively. Since BPs in most of the animals given "100 ug/kg/ 10 min" and "50 jig/kg/ 10 min" had fallen below the baseline BP within 10 min, an administration duration of longer than 10 min will have little influence on the cAUC. With this speculation, All administration of 150 pg/kg/10 min is thoght to be most appropriate as edematogenic method.
Some of the observations herein are highly indicative of a significant connection between the increasing systemic BP and the development of PE. One such finding is that WDRs significantly correlate with cAUCs. As shown in Fig. 5 , WDR is an easily obtainable index that reflects the degree of lung fluid retention to some extent. Although the absolute value of WDR may be influenced by the experimental procedures such as the squeezing process, WDR would be reliable for estimating the degree of fluid retention of the lung if the same procedures are per formed. Ishikawa et al. have documented in their work that 85% of the judgements of PE by critical WDR value correspond with the judgement of PE by the edema froth (14), which is consistent with this study. This similarity would indicate the acceptable reproducibility and respon sibility of WDR. On the other hand, the area under the systemic BP-time curve, a parameter used for evaluating the antihypertensive effect (15), reflects both the extent of increasing BP and its persistent period. In comparison with Dmax or the peak BP, which represents the degree of an increase in BP alone, cAUC seems more suitable for ex plaining the diversity of the incidence of PE between the groups. Thus, WDR and cAUC well-indicate the severity of PE and the changes of BP in this study, respectively.
Because continuing hypertension suggests an increment of cardiac afterload, the significant correlation between the two parameters makes us think that heart failure makes a large contribution to the development of PE.
One concept that may explain the development of PE after a rise of afterload is that of afterload mismatch (16). In short, an increase of afterload will expand the ventricular volume (=increasing preload) to maintain cardiac output. The ventricle can compensate for the added afterload when it is within the limit of the preload reserve, while left heart failure will develop if it exceeds the adaptable range. Failure of the left heart system can result in PE due to increasing hydrostatic pressure. This simple and understandable concept may explain some of the observations in this study. For example, the sequen tial change of dP/dt, a parameter indicating left ven tricular contraction, may be understood as follows: it may decrease initially in response to increasing afterload; then increase gradually according to the recovery of cardiac output caused by the adaptation of preload; and finally, it may decrease again, probably due to the decompensation of the left ventricle. Otherwise, since the PE did not develop in cases that had cAUCs lower than 300 mmHg • min and the PE always occurred when the cAUC exceeded 500 mmHg min, those values may imply the adaptable range of preload reserve. However, the above explanation does not include one essential factor: the change of the original ventricular contractility. The entire mechanism process that occurred after All ad ministration cannot be discussed by this concept alone. Baker et al. have reported that a small dosage of All in creases cardiac work due to not only increased afterload but also increased contractility of the left ventricle (17). The positive inotropic action of All may also play some roles in the present study. From this point of view, addi tional research is required to understand the overall hemodynamic performance.
All receptor inhibitors are currently attractive drugs for clinicians to treat patients with hypertension or heart failure. In particular, losartan is the initially developed, nonpeptide, All type-1 receptor inhibitor that can be given p.o. Regardless of numerous studies, however, the effects of these drugs against the respiratory systems and pulmonary circulation remain to be elucidated. In this study, losartan is given 10 min before All administration. The 10-min interval could be used to obtain a sufficient drug effect and stabilization of BP, because the elimina tion half-life of losartan is sufficiently long (41 min in dogs and 2.1 hr in humans) (18, 19). As a result of the pretreatment, the higher dose of losartan could com pletely prevent the development of PE. This preventive effect of losartan would be attributable to its suppression of the BP elevation in large part. However, the same ex planation can not explain why the lower dose of losartan also prevented PE moderately without apparent suppres sion of the elevation in BP. Because type-1 receptors exist not only in the smooth muscle of vessels but also widely in tissues of the circulatory and respiratory systems (20), mechanisms other than vasodilation may be involved in the action of losartan. In the literature, Yukioka et al. reported that one All antagonist improved gas exchange in the lung and that the improvement of blood gas analy sis may be attributed to the direct action of this drug against the smooth muscle of airway (21). On the other hand, Mookherjee et al. reported no change of gas analy sis or airway resistance (22). Thus, whether these drugs would be effective on respiratory dysfunction or not is still controversial.
Another question that should be answered is the as sociation of permeability factors with the onset of PE. Gil and McNiff pointed out that even a bolus administration of 10 4ug/kg of All to rabbits produces epithelial cell damage rather than endothelial cell damage, the former being commonly observed in lung injury with hyper permeability (12). Concerning adrenaline-induced PE, eicosanoides or cytokines are thought to play some roles in its onset (7). This must be clarified by additional experiments.
In conclusion, we have proposed a rabbit model of PE that is induced by intravenous administration of All, and we also revealed the probable etiology of this form of PE. Moreover, an adequate pretreatment with losartan showed a significant preventive effect against All-induced PE. The present model can be used to clarify the role of All in heart failure and the effectiveness of losartan on the circulatory and respiratory systems.
